AssetMark Inc’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$148K Buy
1,977
+393
+25% +$28.3K ﹤0.01% 1523
2026
Q1
$113K Buy
1,584
+139
+10% +$9.51K ﹤0.01% 1502
2025
Q4
$85.5K Buy
+1,445
New +$78.4K ﹤0.01% 1549
2021
Q2
Sell
-50
Closed -$4K 1473
2021
Q1
$4K Hold
50
﹤0.01% 1056
2020
Q4
$4K Hold
50
﹤0.01% 1070
2020
Q3
$2K Hold
50
﹤0.01% 1135
2020
Q2
$3K Hold
50
﹤0.01% 1028
2020
Q1
$2K Buy
50
+22
+79% +$1.28K ﹤0.01% 1199
2019
Q4
$2K Sell
28
-6
-18% -$525 ﹤0.01% 1250
2019
Q3
$3K Buy
34
+18
+113% +$1.6K ﹤0.01% 1117
2019
Q2
$2K Buy
+16
New +$1.61K ﹤0.01% 1173
2018
Q1
Sell
-17
Closed -$1K 1787
2017
Q4
$1K Buy
+17
New +$1.23K ﹤0.01% 1658

Other funds holding NGVT

AssetMark Inc's NGVT Position: Q2 2026 in Review

AssetMark Inc increased its Ingevity (NGVT) stake by 25% in Q2 2026, buying an estimated $28.3K and bringing the position to 1,977 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #1523.

AssetMark Inc first reported a position in NGVT in Q4 2017 and has held it in 12 quarters since. 315 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.

  • AssetMark Inc held 1,977 shares of Ingevity worth $148K as of Q2 2026.
  • AssetMark Inc bought 393 Ingevity shares in Q2 2026, an estimated $28.3K.
  • Ingevity made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #1523 holding.
  • AssetMark Inc first reported a position in Ingevity in Q4 2017 and has held it in 12 quarters since.
  • 315 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.